Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Adjuvant Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Adjuvant Therapymarket, defines the market attractiveness level of Adjuvant Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Adjuvant Therapy industry, describes the types of Adjuvant Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Adjuvant Therapy market and the development prospects and opportunities of Adjuvant Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Adjuvant Therapy market in Chapter 13.
By Player:
Bayer
Johnson and Johnson
AstraZenca
Mylan
Novartis
Merck
AbbVie
By Type:
Chemotherapy
Radiotherapy
Hormonotherapy
Others
By End-User:
Hospital
Medical Institution
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Adjuvant Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Adjuvant Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Adjuvant Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Adjuvant Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Adjuvant Therapy Market Analysis and Outlook to 2022
-
7.1 Global Adjuvant Therapy Consumption (2017-2022)
-
7.2 United States Adjuvant Therapy Consumption (2017-2022)
-
7.3 Europe Adjuvant Therapy Consumption (2017-2022)
-
7.4 China Adjuvant Therapy Consumption (2017-2022)
-
7.5 Japan Adjuvant Therapy Consumption (2017-2022)
-
7.6 India Adjuvant Therapy Consumption (2017-2022)
-
7.7 South Korea Adjuvant Therapy Consumption (2017-2022)
8 Region and Country-wise Adjuvant Therapy Market Analysis and Outlook to 2028
-
8.1 Global Adjuvant Therapy Consumption Forecast (2022-2028)
-
8.2 United States Adjuvant Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Adjuvant Therapy Consumption Forecast (2022-2028)
-
8.4 China Adjuvant Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Adjuvant Therapy Consumption Forecast (2022-2028)
-
8.6 India Adjuvant Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Adjuvant Therapy Consumption Forecast (2022-2028)
9 Global Adjuvant Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Adjuvant Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hormonotherapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Adjuvant Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Institution Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Adjuvant Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Adjuvant Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hormonotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Adjuvant Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Institution Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Adjuvant Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Adjuvant Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Adjuvant Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Adjuvant Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Adjuvant Therapy Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Adjuvant Therapy Product and Service
-
14.2 Johnson and Johnson
-
14.2.1 Johnson and Johnson Company Details
-
14.2.2 Johnson and Johnson Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson and Johnson Adjuvant Therapy Product and Service
-
14.3 AstraZenca
-
14.3.1 AstraZenca Company Details
-
14.3.2 AstraZenca Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZenca Adjuvant Therapy Product and Service
-
14.4 Mylan
-
14.4.1 Mylan Company Details
-
14.4.2 Mylan Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mylan Adjuvant Therapy Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Adjuvant Therapy Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Adjuvant Therapy Product and Service
-
14.7 AbbVie
-
14.7.1 AbbVie Company Details
-
14.7.2 AbbVie Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie Adjuvant Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Adjuvant Therapy
-
Figure Adjuvant Therapy Picture
-
Table Global Adjuvant Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Adjuvant Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Adjuvant Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Adjuvant Therapy Consumption by Country (2017-2022)
-
Figure United States Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Adjuvant Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Adjuvant Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Adjuvant Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Institution Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Institution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Adjuvant Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Adjuvant Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Adjuvant Therapy Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Adjuvant Therapy Product and Service
-
Table AstraZenca (Foundation Year, Company Profile and etc.)
-
Table AstraZenca Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZenca Adjuvant Therapy Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Adjuvant Therapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Adjuvant Therapy Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Adjuvant Therapy Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Adjuvant Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Adjuvant Therapy Product and Service
-
